Projected 2018 revenue for top 10 drugs approved U.S. 2013
This statistic displays the projected 2018 revenue for top 10 drugs approved in the U.S. in 2013. Tivicay, approved on August 12, 2013, and developed by GlaxoSmithKline, is estimated to generate 2.13 billion U.S. dollars in annual revenue in 2018. Pharmaceutical and biotechnology companies experienced widespread growth worldwide with the United States garnering the largest growth.
